Özet:

Lymphocyte leukemia/lymphoma (ATLL) is a fringe T-cell harm brought about by human T-cell leukemia infection type. Lymphocyte leukemia (ATL) is an exceptionally forceful developed T-cell neoplasm related with human T-cell lymphotropic infection type 1 (HTLV-1) contamination, which influences around 10 million individuals on the planet. Of them, roughly 1-5% at last creates indicative ATL. Patient history: A 15 years male was admitted in AVBRH with complaint of fever, decrease appetite from 1 month, vomiting with blood tinged food particles and melena. Patient was diagnosed case of T-cell variant ALL. Before coming to AVBRH he was admitted to GMC Nagpur where he was diagnosed to had T-cell ALL with aberrant expression of CD10. He also had generalised lymphadenopathy and massive hepatosplenomegaly. He was advised blood transfusion but gives no H/O the same. Then he was discharged. After that patient developed malaena and blood tinged vomiting for which he came to AVBRH for further management. After his arrival, he was covid-19 positive so shifted to COVID ward. After two weeks, RTPCR status was negative then he shifted to PICU. .Clinical finding: The patient had done all necessary investigations by physician order. Medical Management: Patient was treated with IV. Fluids, platelet transfusion, chemotherapy, steroids, calcium gluconate, antibiotics, antacid, vit c and multivitamins. Nursing management: Administered fluid replacement i.e. D5, chemotherapy, platelet transfusion monitored all vital signs half hourly. Conclusion: Timely treatment and management of T-cell ALL with aberrant expression of CD10 with post COVID-19 infection.

Anahtar Kelimeler: